You searched for "foundation"
Ophthalmology Made Easy
4 December 2024
| Jacob Clark
|
EYE - General
Ophthalmology Made Easy by Michelle Attzs and Twishaa Sheth is a concise yet comprehensive guide that delivers essential ophthalmic knowledge in a digestible format. This book stands out for its accessibility and clarity, making it an invaluable resource for medical...
Burnout: ubiquitous and unavoidable?
3 August 2023
| Meriam Islam
|
EYE - General
Meriam Islam reminds us of the importance of ‘putting our oxygen mask on first’ and avoiding burnout while we progress through our careers. Burnout. It’s a term we hear a lot. What does it mean though? According to Merriam Webster,...
Will COVID-19 impact the selection of ophthalmology as a career choice by medical students?
10 December 2020
| Dalia Abdulhussein
|
EYE - General
The COVID-19 pandemic has had profound effects on medical education and has called for large shifts in the medical curriculum. Clinical attachments were suspended at the height of the pandemic and examinations were cancelled or were moved to an online...
Ophthalmology Scholarship Applications Open – Deadline 1 June 2021
25 January 2021
The University of Edinburgh has opened applications for The David and Molly Pyott Foundation Scholarships in Ophthalmology which will support eligible ophthalmology trainees / registrars /residents undertake the university’s online, two-year, part-time ChM (Master of Surgery) in Clinical Ophthalmology from September 2021.
Oculomics and Big Data changes the game for Medical Ophthalmologists
25 September 2023
| Nima John Ghadiri
|
oculomics, Nima Ghadiri, big data, ai, artificial intelligence, RETFound, Alastair Denniston
Oculomics and Big Data changes the game for Medical Ophthalmologists, and here's why.
Moorfields Eye Hospital, UCL Institute of Ophthalmology and Topcon Healthcare, Inc. launch Cascader Limited to advance AI-driven eyecare and Oculomics
9 May 2025
|
AI, Artificial intelligence, oculomics, news, Moorfields, Cascader, imaging, industry news
Moorfields Eye Hospital NHS Foundation Trust, the UCL Institute of Ophthalmology (IoO), and Topcon Healthcare today announced the launch of Cascader Limited, a new medical technology company that aims to transform the detection and management of eye disease through artificial...
Should points for simulated surgery be removed from the ophthalmology ST1 evidence folder?
2 April 2025
| Harriet Fallon
|
EYE - General
The benefits of the Eyesi surgical simulator by Haag-Streit UK for early career ophthalmology speciality trainees are well-established, allowing for the practice of cataract and vitreoretinal surgery in a controlled, risk-free environment. Whilst the Eyesi is an invaluable resource for...
UK Eye Genetics Group (UK-EGG) 2024
10 June 2024
by Mohammed Aslam, FY 3 Doctor, Calderdale and Huddersfield NHS Foundation Trust, UK. Founded in 2002, the UK EGG provides a hub to share knowledge on inherited eye disease and train the next generation of clinicians and scientists. This year’s...
Gene Vision launched to support those diagnosed with genetic eye diseases
2 December 2020
A new website, Gene Vision (https://gene.vision), has been developed by Professor Mariya Moosajee and Dr Alex Yeong, supported by Dr Peter Thomas (Director of Digital Innovation at Moorfields Eye Hospital). The new site is intended for adults, children and their families who are diagnosed with rare genetic eye diseases.
Updated staging of LCHADD retinopathy
2 August 2024
| Ian Reekie
|
EYE - Vitreo-Retinal
The authors present their proposal for an updated staging system for Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) deficiency retinopathy. This is a rare mitochondrial disease due to deficiency of the long chain fatty acid oxidation pathway. Forty patients who were part of...
Effective treatment for rare sight-threatening infection
A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.
